VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
TRNS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
TRNSTranscat, Inc.
$91.28$853M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksTRNSBalance Sheet

Transcat, Inc. (TRNS) Balance Sheet

30Y historyFree accessUpdated daily

The company's reliance on debt-funded acquisitions has pushed total debt to $128.9M, resulting in a debt-to-equity ratio of 0.43 compared to 0.10 in 2023Q3.

TRNS Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricMar'26Mar'25Mar'24Mar'23Mar'22Mar'21Mar'20Mar'19Mar'18Mar'17Mar'16Mar'15Mar'14Mar'13Mar'12Mar'11Mar'10Mar'09Mar'08Mar'07Mar'06Mar'05Mar'04Mar'03Mar'02Mar'01Mar'00Mar'99Mar'98Mar'97
Total Current Assets92.46M78.01M105.16M67.6M59.7M48.93M48.46M45.01M40.51M35.59M26.22M27.14M25.53M25.82M23.18M21.75M19.37M15.2M16.39M15.5M13.83M15.04M13.29M11.25M14.38M21.64M24.1M28.1M25.8M16.7M
Cash & Short-Term Investments4.94M1.52M35.18M1.53M1.4M560K499K788K577K842K641K65K23K406K32K32K123K59K208K357K115K106K547K114K508K176.83K508.45K300K700K800K
Cash Only4.94M1.52M19.65M1.53M1.4M560K499K788K577K842K641K65K23K406K32K32K123K59K208K357K115K106K547K114K508K176.83K508.45K300K700K800K
Short-Term Investments0015.53M000000000000000000000000000
Accounts Receivable65.84M56.31M48.28M45.2M40.3M34.38M32.08M28.59M26.05M23.28M17.96M18.07M16.75M16.39M14.64M12.68M11.86M9.1M9.72M9.2M7.99M8.4M8.25M7.84M9M11.61M12.6M13.3M12.5M6.8M
Days Sales Outstanding72.4173.8367.9271.5671.7672.3967.6564.8561.2859.0453.6653.3551.5953.2748.5950.7653.3944.0450.3450.5148.2255.4556.4950.0349.256.0857.569.6558.1252.47
Inventory13.71M14.48M17.42M16.93M12.71M11.64M14.18M14.3M12.65M10.28M6.52M6.75M6.18M6.8M6.4M7.57M5.91M4.89M5.44M4.34M3.95M5.9M3.74M2.84M3.87M8.4M8.83M12M10.7M7.8M
Days Inventory Outstanding22.3727.9736.1938.0931.6733.3839.6242.9539.2334.4425.5826.0625.4329.2528.1640.7134.931.4838.2631.7931.7952.0234.1623.6328.7463.8960.87100.9277.03102.78
Other Current Assets7.97M5.7M4.28M3.94M0001.33M1.24M1.19M01.05M1.4M1.09M2.1M631K566K380K248K851K1.77M000225K411.29K2.16M2.5M1.9M1.3M
Total Non-Current Assets388.02M307.23M182.39M128.15M118.06M83.19M79.66M60.22M56.31M56.51M50.49M35.01M28.34M29.23M21.8M19.61M16.35M14.19M7.96M6.92M7.66M5.07M5.09M5.51M13.25M26.09M28.26M29.2M26.1M9.2M
Property, Plant & Equipment57.8M74.37M55.77M43.94M37.47M31.59M29.43M19.65M17.09M15.57M12.31M9.4M7.09M6.88M5.31M5.25M4.16M4.17M3.21M2.81M2.64M1.98M2.21M2.56M3.91M5.75M6.54M6.9M6.4M2.4M
Fixed Asset Turnover5.74x3.74x4.65x5.25x5.47x5.49x5.88x8.19x9.08x9.24x9.92x13.16x16.72x16.31x20.74x17.36x19.47x18.07x21.94x23.62x22.93x27.88x24.17x22.37x17.08x13.15x12.22x10.10x12.27x19.71x
Goodwill218.19M176.93M105.58M69.36M65.07M43.27M41.54M34.55M32.74M32.52M29.11M20.92M17.38M17.59M13.39M11.67M10.04M7.92M2.97M2.97M2.97M000000000
Intangible Assets77.71M54.78M19.99M13.8M14.69M7.51M7.98M5.23M5.5M7.52M8.21M3.55M2.65M3.69M2.45M1.98M1.23M1.09M0002.52M2.52M2.52M9M19.92M21.25M21.7M19.2M5.9M
Long-Term Investments0100K00000500K700K700K700K-1.05M-1.4M-1.09M-1.04M000000000000000
Other Non-Current Assets34.33M1.06M1.05M1.05M827K808K719K-1.58M-1.41M-2.53M-2.77M1.13M1.22M1.06M654K408K378K368K344K346K434K564K364K431K340K423.57K468.77K600K500K900K
Total Assets480.49M385.24M287.55M195.75M177.76M132.12M128.12M105.23M96.82M92.1M76.71M62.15M53.87M55.05M44.98M41.36M35.71M29.39M24.34M22.42M21.49M20.11M18.39M16.76M27.62M47.72M52.36M57.3M51.9M25.9M
Asset Turnover0.69x0.72x0.90x1.18x1.15x1.31x1.35x1.53x1.60x1.56x1.59x1.99x2.20x2.04x2.45x2.20x2.27x2.57x2.89x2.96x2.81x2.75x2.90x3.41x2.42x1.58x1.53x1.22x1.51x1.83x
Asset Growth %24.72%33.97%46.9%10.12%34.55%3.12%21.75%8.68%5.13%20.06%23.42%15.36%-2.13%22.39%8.75%15.81%21.51%20.73%8.57%4.35%6.84%9.39%9.71%-39.34%-42.11%-8.86%-8.62%10.4%100.39%64.97%
Total Current Liabilities39.63M34.04M33.5M28.32M27.71M25.14M20.92M22.15M21.15M19.76M15.83M11.93M13.86M13.33M13.05M12.03M12.22M6.72M8.5M7.93M10.83M13M13.07M6.43M10.01M12.57M12.22M15.8M15.6M6.9M
Accounts Payable17.93M16.75M11.49M15.87M14.17M12.28M11.95M14.57M13.54M11.62M8.14M7.7M7.13M8.88M7.52M8.24M8.8M4.75M5.95M5.31M4.22M4.54M4.14M3.74M6.34M6.63M7.1M11.4M7.9M3.6M
Days Payables Outstanding29.2732.3623.8835.7135.335.2233.3843.7641.9738.9231.9429.7129.3438.1933.0944.3151.9930.5841.8138.9133.9440.0537.8431.0847.0950.4348.9495.8856.8747.44
Short-Term Debt01.82M2.34M2.25M2.16M2.07M1.98M1.9M2.14M1.43M00000000003.98M6.32M7.16M666K1.02M3.98M2.7M2.2M5.4M600K
Deferred Revenue (Current)0000000228K232K805K00000000002.53M1.99M1.62M1.86M000000
Other Current Liabilities21.7M1.14M620K1.13M11.38M10.42M6.91M5.45M5.24M5.91M7.69M4.2M1.03M3.98M000062K42K102K5K157K214K693K1.96M2.42M2.2M2.3M2.7M
Current Ratio2.33x2.29x3.14x2.39x2.15x1.95x2.32x2.03x1.92x1.80x1.66x2.27x1.84x1.94x1.78x1.81x1.58x2.26x1.93x1.96x1.28x1.16x1.02x1.75x1.44x1.72x1.97x1.78x1.65x2.42x
Quick Ratio1.99x1.87x2.62x1.79x1.70x1.48x1.64x1.39x1.32x1.28x1.24x1.71x1.40x1.43x1.29x1.18x1.10x1.53x1.29x1.41x0.91x0.70x0.73x1.31x1.05x1.05x1.25x1.02x0.97x1.29x
Cash Conversion Cycle65.5169.4480.2373.9468.1270.5673.8964.0458.5354.5647.349.747.6844.3243.6547.1636.344.9446.7943.3946.0767.4252.8142.5730.8469.5469.4374.6978.28107.82
Total Non-Current Liabilities140.24M64.33M28.88M67.8M63.88M31.9M40.11M23.45M24.32M28.94M21.97M15.9M9.93M10.07M4.55M6M3.24M4.05M729K3.27M2.02M2.8M1.88M7.63M10.85M21.82M27.32M26.6M22.3M6.6M
Long-Term Debt99.88M30.89M1.82M46.87M46.29M17.49M28.36M19.1M20.71M25.88M19.07M12.17M7.59M8.02M3.37M5.25M2.53M3.56M302K2.9M353K1.02M134K5.92M8.9M21.22M26.69M26.2M21.8M6M
Capital Lease Obligations29M21.39M14.87M12.96M9.19M7.96M6.83M0000000000000056K134K0000000
Deferred Tax Liabilities10.17M9.29M9.29M6.54M6.72M3.2M3.02M2.45M1.71M1.13M1.07M1.68M607K551K139K0000000000304.67K269.48K000
Other Non-Current Liabilities1.19M2.75M2.9M1.43M1.67M3.24M1.89M1.9M1.91M1.92M1.82M2.05M1.73M1.5M1.04M750K704K493K427K366K1.66M1.73M1.61M1.71M1.96M293.83K360.11K400K500K600K
Total Liabilities179.87M98.36M62.38M96.12M91.59M57.04M61.03M45.6M45.47M48.7M37.8M27.83M23.79M23.4M17.6M18.03M15.46M10.77M9.23M11.19M12.84M15.8M14.96M14.06M20.86M34.39M39.55M42.4M37.9M13.5M
Total Debt128.88M57.73M21.54M64.41M57.65M27.52M37.18M21M22.85M27.31M19.07M12.17M7.59M8.02M3.37M5.25M2.53M3.56M302K2.9M4.33M7.4M7.29M6.58M9.91M25.2M29.39M28.4M27.2M6.6M
Net Debt123.94M56.21M1.89M62.88M56.25M26.96M36.68M20.21M22.27M26.47M18.43M12.1M7.57M7.61M3.33M5.22M2.41M3.5M94K2.54M4.21M7.29M6.75M6.47M9.4M25.03M28.88M28.1M26.5M5.8M
Debt / Equity0.43x0.20x0.10x0.65x0.67x0.37x0.55x0.35x0.45x0.63x0.49x0.35x0.25x0.25x0.12x0.23x0.12x0.19x0.02x0.26x0.50x1.71x2.13x2.44x1.47x1.89x2.29x1.91x1.94x0.53x
Debt / EBITDA3.27x1.58x0.65x2.37x2.43x1.48x2.12x1.27x1.52x1.93x1.86x1.23x0.79x0.93x0.40x0.76x0.57x0.78x0.06x0.52x1.46x2.94x4.28x2.65x3.83x3.36x5.96x4.12x3.94x1.50x
Net Debt / EBITDA3.14x1.54x0.06x2.31x2.37x1.45x2.09x1.22x1.48x1.87x1.80x1.23x0.78x0.88x0.40x0.76x0.54x0.76x0.02x0.46x1.42x2.89x3.96x2.61x3.63x3.34x5.86x4.07x3.84x1.32x
Interest Coverage2.51x23.96x11.05x6.58x17.28x10.15x9.69x10.29x8.47x10.30x21.36x19.62x27.05x26.08x40.51x62.40x37.24x26.19x32.50x7.03x3.18x1.73x0.71x0.76x------
Total Equity300.62M286.88M225.17M99.63M86.18M75.08M67.09M59.63M51.35M43.4M38.91M34.32M30.08M31.65M27.38M23.33M20.26M18.62M15.12M11.23M8.65M4.31M3.43M2.7M6.76M13.33M12.81M14.9M14M12.4M
Equity Growth %4.79%27.41%126.01%15.61%14.78%11.91%12.51%16.13%18.31%11.54%13.38%14.08%-4.95%15.6%17.36%15.17%8.8%23.17%34.62%29.86%100.44%25.85%27.06%-60.11%-49.25%4.02%-14%6.43%12.9%51.22%
Book Value per Share32.2131.0026.9613.0311.369.958.967.937.036.105.464.864.094.173.583.102.682.492.081.531.200.620.500.441.112.342.132.382.241.98
Total Shareholders' Equity300.62M286.88M225.17M99.63M86.18M75.08M67.09M59.63M51.35M43.4M38.91M34.32M30.08M31.65M27.38M23.33M20.26M18.62M15.12M11.23M8.65M4.31M3.43M2.7M6.76M13.33M12.81M14.9M14M12.4M
Common Stock4.67M4.66M4.42M3.78M3.77M3.73M3.69M3.6M3.58M3.52M3.46M3.42M3.36M3.71M3.92M3.88M3.85M3.83M3.72M3.64M3.52M3.35M3.18M3.15M3.12M3.09M3.05M000
Retained Earnings97.76M92.52M80.07M69.16M58.74M52.51M46.48M40.17M33.09M27.3M22.81M18.75M14.81M16.84M14.39M11.09M8.3M6.85M5.3M2.93M875K-2.7M-2.96M-3.31M1.4M8.04M7.52M10M9M8M
Treasury Stock00000000000000-2.19M-2.19M-1.64M-988K-988K-988K-888K-838K-453K-453K-453K-453.31K-453.31K-500K00
Accumulated OCI-923K-1.47M-949K-1.2M-233K-451K-1.01M-611K-281K-414K-358K-143K567K481K448K485K382K320K436K372K495K509K428K283K-326K-305.16K-131.69K-6.8M-5.7M-4.4M
Minority Interest000000000000000000000000000000

Key Metrics

Growth RegimeExpanding
ProfitabilityStrained
Balance SheetHealthy
Cash FlowMixed
Top Statement Risk

Goodwill impairment and leverage

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2025Q4)

Asset Expansion Outpacing Organic Growth

According to recent balance sheet data, Transcat's total assets have surged from $281.1M in 2023Q3 to $480.5M by 2025Q4, a trajectory primarily driven by aggressive inorganic acquisitions that have fundamentally altered the company's capital structure and increased its reliance on intangible assets over tangible operational capacity.

The rapid expansion of the asset base suggests a management team focused on scaling through acquisition rather than organic laboratory development. Investors should monitor whether this asset growth translates into improved operating margins, as the current trend indicates that the company is becoming increasingly asset-heavy without a commensurate improvement in profitability.

Leverage Rising to Fund Acquisitions

As reported in financial statements, Transcat's total debt has climbed from $22.1M in 2023Q3 to $128.9M in 2025Q4, reflecting a strategic shift toward utilizing debt to finance its roll-up strategy, which has pushed the debt-to-equity ratio from 0.10 to 0.43 over the same period.

While a 0.43 debt-to-equity ratio remains manageable, the sharp increase in debt warrants investigation into the company's interest coverage capacity, especially given the thin operating margins. This leverage appears to be a necessity-driven component of the acquisition model rather than a strategic optimization of the capital structure.

Goodwill Concentration Risks Asset Quality

Based on the company's reported figures, goodwill has ballooned from $105.7M in 2023Q3 to $218.2M in 2025Q4, now representing nearly 45% of total assets, which suggests that the company's valuation is increasingly sensitive to the successful integration and long-term performance of its acquired calibration laboratory network.

The high concentration of goodwill relative to total assets implies that any underperformance in acquired units could lead to significant impairment charges. This asset mix highlights a reliance on intangible synergies that may be difficult to realize if the competitive landscape for specialized calibration services intensifies.

Cash Buffer Diminishing Amid Expansion

As indicated by quarterly filings, Transcat's cash position has contracted significantly from $35.2M in 2023Q3 to just $4.9M in 2025Q4, signaling that the company is aggressively deploying its liquid reserves to fund ongoing acquisition activity and support its working capital requirements in a high-growth environment.

The reduction in cash reserves suggests a tightening liquidity profile that may limit the company's flexibility to respond to unexpected operational shocks or further acquisition opportunities. Investors should monitor the current ratio, which, while stable at 2.33, may mask the underlying lack of cash available for immediate operational contingencies.

TRNS — Frequently Asked Questions

Quick answers to the most common questions about buying TRNS stock.

What are the total assets of Transcat, Inc. (TRNS)?

As of 2025, Transcat, Inc. (TRNS) had total assets of $480.5M including $92.5M in current assets.

How much debt does Transcat, Inc. (TRNS) have?

Transcat, Inc. (TRNS) carries total debt of $128.9M, offset by $4.9M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Transcat, Inc.?

Transcat, Inc. (TRNS) has total shareholders' equity (book value) of $300.6M ($32.21 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Transcat, Inc.'s current ratio and liquidity?

Transcat, Inc. (TRNS) reported a current ratio of 2.33x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.